Naratriptan Hydrochloride
Who holds supplier records for Naratriptan Hydrochloride? 4 organisations hold a current record for Naratriptan Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Naratriptan Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/naratriptan-hydrochloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Naratriptan Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 17648 · latest filing Aug 2004
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 22131 · latest filing Dec 2008
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 22729 · latest filing May 2009
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 22953 · latest filing Aug 2009
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Naratriptan Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 22621 · filed Mar 2009
- India · Inactive DMF 22422 · filed Dec 2008
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Naratriptan Hydrochloride is a selective serotonin receptor agonist used in the treatment of migraines. It works by narrowing blood vessels around the brain and reducing substances in the body that trigger headache pain, nausea, sensitivity to light and sound.
Chemical identity
- IUPAC name
- N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;hydrochloride
- Canonical SMILES
- CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl
- InChIKey
- AWEZYKMQFAUBTD-UHFFFAOYSA-N
- Synonyms
- Amerge API, amerge, gr 85548a, gr-85548a, naratriptan hcl
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin-1b and Serotonin-1d Receptor Agonist
- Mechanism of action
- Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Naratriptan Hydrochloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Naratriptan Hydrochloride: Dr. Reddy's Laboratories Ltd. (India), ORBION PHARMACEUTICALS PRIVATE LTD (India), Sun Pharmaceutical Industries Limited (India) and USV PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Naratriptan Hydrochloride Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 17648), ORBION PHARMACEUTICALS PRIVATE LTD (DMF 22131), Sun Pharmaceutical Industries Limited (DMF 22729) and USV PRIVATE LTD (DMF 22953). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Naratriptan Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Naratriptan Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Naratriptan Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Naratriptan Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.